Pharmacological interventions for children with Disruptive Behaviour Disorders or Conduct Disorder or Oppositional Defiant Disorder
Pharmacological interventions (such as methylphenidate, lithium, carbamazepine and risperidone) should not be offered by non-specialized health care providers to treat Disruptive Behaviour Disorders (DBD), Conduct Disorder (CD), Oppositional Defiant Disorder (ODD) and comorbid Attention-Deficit Hyperactivity Disorder (ADHD). For these conditions, the patients should be referred to specialist before prescribing any medicines.
Strength of recommendation: STRONG
Quality of evidence: LOW